Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUAL: Darunavir/Ritonavir + Lamivudine vs Triple Therapy in HIV
NCT02159599Phase 4Completed
- Sponsor
- Fundación SEIMC-GeSIDA
- Start
- Jul 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of darunavir, lamivudine in human immunodeficiency virus infection (HIV), sponsored by Fundación SEIMC-GeSIDA. Started Jul 2014; status: completed.
02
Drugs
darunavirlamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02159599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02159599.